In this real-world population of stage III colon cancer patients, adjuvant CAPOX was associated with an improved 3-year disease-free survival compared to FOLFOX (83.8% vs. 73.4%, P = .022), which supports recent results from the International Duration Evaluation of Adjuvant Chemotherapy (IDEA)...
原始出处 Jeffrey A. Meyerhardt et al. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial .JAMA....
even in patients with KRAS wild-type tumors. The disease-free survival rate at 3 years was 75.1% in 791 patients given FOLFOX4 with cetuximab and 78% in 811 patients in the control group.
10.Andre T, de Gramont A, Vernerey D,et al.Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.J Clin Oncol ...
Analysis of disease-free survival rate and overall survival time and the inflaendng factors in elderly patients with stage Ⅱ and Ⅲ performed FOLFOX or XELOX chemotherapy after radical resection of colon cancer[J]. Journal of Clinical and Experimental Medicine, 2018,17(8):853-856. DOI: ...
"Longer follow-up confirms the benefit of FOLFOX4, showing that the benefit of prevention of relapse already seen now actually translates into a survival advantage for patients with stage 3 colon cancer," the team reported. Dr. de Gramont pointed out that long-term data show no increase in ...
PURPOSE: The seventh edition of the American Joint Committee on Cancer (AJCC) staging system has new substages for colon cancer. We used survival data from... YT Lan,SH Yang,SC Chang,... - 《International Journal of Colorectal Disease》 被引量: 69发表: 2012年 康莱特注射液治疗晚期非小细胞...
Results A total of 12 articles were included in the study, with 1 614 colon cancer patients, 801 to the FOLFOX group and 813 to the XELOX group.There was no significant difference in overall response, complete response, partial response, overall survival, and progression-free survival between ...
pyfor6cyclesincoloncancer patients.[MethodslClinicaldataof19patientswhohadreceivedFOIF0adjuvantchemothera pyfor6weeksfromApril2004 toOctober2006inourhospitalwereanalyzedretrospectively.The3-yeardiseasefreesurviva l(DFS)andoverallsurvival(0S) werecomparedbetweenourpatients(chemotherapyfor6cycles)andpatientsinF()LF...
improvingpostoperativedisease-freesurvival,5-yearsurvival, andqualityoflife。However,theXELOXregimenhasfewer sideeffectsandbetterpatientcomplianceandtolerance。 Keywords:Coloncancer;Capecitabine; Oxaliplatin;Fluorouracil 结肠癌(coloncancer)是消化道常见的恶性肿瘤,随着我 ...